ENGLISH
|
JAPANESE
|
CONNECT WITH US:
Home
About
Contact
Log in
*
Home
Press release
Nov 06, 2019 00:05 JST
Source:
Jacobson Pharma Corporation Limited
Jacobson Pharma Adds Excilor to Its Portfolio to Develop China Market with Vemedia (The Netherlands)
HONG KONG, Nov 05, 2019 - (ACN Newswire) - Jacobson Pharma Corporation Limited ("Jacobson Pharma" or the "Company"; Stock Code: 2633), a leading company engaged in research, development, production, marketing and sale of generic drugs and proprietary medicines, announced today that its wholly-owned subsidiary Jacobson Medical (Hong Kong) Limited ("Jacobson") has signed an exclusive distribution agreement (the "Agreement") with Vemedia Shine Limited ("Vemedia") (a wholly-owned subsidiary of Versailles B.V., a company incorporated in the Netherlands) for the marketing and distribution of "Excilor" range of products in the market of Mainland China.
Photo for product(s) of Excilor being currently sold in Hong Kong. Excilor is a leading over-the-counter brand in Hong Kong for nail and foot care.
Jacobson will be the exclusive distributor for Vemedia for the marketing, sales and distribution of Vemedia's highly recognised medicated nail and foot care brand, namely "Excilor", in the China market for a term of ten years.
Mr. Derek Sum, Chairman and Chief Executive Officer of Jacobson Pharma remarked, "The strategic collaboration represents a sound leverage of strengths and resources between Jacobson and Vemedia. By riding on its established market network, Jacobson Pharma aims to build a strong position for the Excilor brand whilst tapping the fast-growing nail and foot care market in China. It is one of our strategic goals to maximize the value and market potential of the Excilor brand and create synergies with Vemedia via a sustainable collaboration."
The appointment of Jacobson as the exclusive distributor of Excilor in the Mainland China will enhance the product portfolio of Jacobson Pharma and further strengthen its market position in capitalizing on the rising consumer demand for branded healthcare products in the burgeoning market of China.
Jacobson Pharma has been forging strategic collaborations with various business partners. A case in point is the recently-formed joint venture alliance with Weisen-U and Flucur Nebuliser. The Group currently possesses a portfolio of proprietary healthcare brands such as Po Chai Pills, Ho Chai Kung Tji Thung San, Contractubex Scar Gel, Flying Eagle Wood Lok Medicated Oil, Tong Tai Chung Woodlok Oil, Doan's Ointment, Saplingtan, Shiling Oil, and Col-gan Tablet.
About Jacobson Pharma Corporation Limited (Stock Code: 2633)
Jacobson Pharma is a leading generic drug company in Hong Kong. The Group's proprietary medicines, notably being Po Chai Pills, Ho Chai Kung Tji Thung San, Contractubex Scar Gel, Flying Eagle Wood Lok Medicated Oil, Tong Tai Chung Woodlok Oil, Doan's Ointment, Saplingtan, Shiling Oil and Col-gan Tablet have been widely recognised by the market. The Group aims to enrich its portfolio through addition of high value-added products covering sterile injections, oncology products as well as orphan drugs and biosimilars. With its corporate headquarters based in Hong Kong, the Group has also established its operating subsidiaries in China, Macau, Taiwan, Singapore and Cambodia forming a regional commercial platform to tap the market potential in the Asia Pacific and Greater China region. Jacobson Pharma has been a constituent stock of MSCI Hong Kong Micro Cap Index since 1 June 2017. For more details about Jacobson Pharma, please visit the Group's website:
http://www.jacobsonpharma.com
About Vemedia Shine Limited
Vemedia is a fast growing reputable consumer healthcare company headquartered in Diemen, the Netherlands, marketing a portfolio of leading self-medicated brands in certain European countries. Excilor, a well-recognized brand under Vemedia, primes itself as the specialist in medical foot care and enjoys a preeminent position in the over-the-counter (OTC) market for the treatment of fungal nail infection.
Source: Jacobson Pharma Corporation Limited
Sectors: Daily Finance, Healthcare & Pharm
Copyright ©2024 ACN Newswire. All rights reserved. A division of Asia Corporate News Network.
Latest Release
Eisai Completes Rolling Submission to US FDA for LEQEMBI(R) (lecanemab-irmb) Biologics License Application for Subcutaneous Maintenance Dosing for the Treatment of Early Alzheimer's Disease Under the Fast Track Status
Nov 01, 2024 13:56 JST
All-New Triton Wins Golden Award at VMARK Vietnam Design Awards 2024
Nov 01, 2024 12:43 JST
Fujitsu's groundbreaking computing technology for accelerating scientific computing wins Japan Patent Office Commissioner's Award
Nov 01, 2024 12:24 JST
Fujitsu and AMD to begin strategic partnership to develop more sustainable computing infrastructure intended to accelerate open-source AI initiatives
Nov 01, 2024 10:45 JST
Mazda Launches Redesigned Corporate Website
Oct 31, 2024 17:06 JST
NTT and Toyota Motor Corporation agree to joint initiative in the field of mobility and AI/telecommunications with the aim of realizing a society with zero traffic accidents
Oct 31, 2024 16:34 JST
All-New Triton Wins Golden Award at VMARK Vietnam Design Awards 2024
Oct 31, 2024 16:08 JST
Eisai Presents Data on Benefits of Long-Term Administration of Dual-Acting Lecanemab at the 17th Clinical Trials for Alzheimer's Disease (CTAD) Conference
Oct 31, 2024 13:56 JST
Eisai Presents Latest Clinical Findings Suggesting Inhibition of Tau Propagation by Anti-MTBR Tau Antibody E2814 at the 17th Clinical Trials on Alzheimer's Disease Conference (CTAD)
Oct 31, 2024 11:33 JST
Mazda Production and Sales Results for September 2024 and for April through September 2024
Oct 30, 2024 17:09 JST
Suzuki and Toyota to Deepen Collaboration in the Field of Electrified Vehicles
Oct 30, 2024 16:14 JST
Fujitsu and Morinaga Milk Industry jointly develop a simulation system for raw material price fluctuations, speeding up decision-making
Oct 30, 2024 13:43 JST
DOCOMO to Participate in Virtual Expo at Expo 2025 Osaka, Kansai, Japan
Oct 30, 2024 12:47 JST
ULVAC Launches Technology Center PYEONGTAEK for Next-Gen Semiconductor Manufacturing Equipment in South Korea
Oct 30, 2024 11:00 JST
Fujitsu and Linius partner to unlock the power of video worldwide
Oct 29, 2024 19:53 JST
DENSO and U.S. Startup Quadric Sign Development License Agreement for AI Semiconductor (NPU)
Oct 29, 2024 13:03 JST
Toyota Motor Corporation and Hyundai Motor Company Co-host Motorsport Event to Share the Excitement of Racing
Oct 28, 2024 20:53 JST
NEC launches new end to end private 5G solution with Cisco
Oct 28, 2024 17:05 JST
Mitsubishi Power Receives Order for Facility Retrofit at the Darajat Geothermal Power Plant in Indonesia
Oct 28, 2024 15:35 JST
GS Holdings to Acquire Integrated Beverage Solutions Group, Octopus Distribution Networks, for S$11.8 Million; Expected to Yield Significant Opportunities and Additional Financial Benefits
Oct 28, 2024 09:00 JST
More Latest Release >>
Related Release
Jacobson Pharma Announces FY2023 Interim Results
November 25 2022 21:21 JST
Jacobson Pharma Announces FY2022 Annual Results
June 29 2022 23:20 JST
Ban Loong, Jacobson & JBM Form Joint Venture to Tap Specialty Drugs and Branded Healthcare Markets in Greater China and Asia
June 15 2022 19:56 JST
Jacobson Pharma's Chairman Uplifts Shareholding to Above 60%
March 14 2022 19:58 JST
Jacobson Pharma Announces FY2022 Interim Results
November 26 2021 19:39 JST
Jacobson Pharma Announces FY2021 Annual Results
June 29 2021 23:19 JST
JBM (Healthcare) Limited Debuts on The Main Board of SEHK
February 05 2021 16:28 JST
JBM (Healthcare) Limited to Be Spun Off from Jacobson Pharma Corporation Limited
January 25 2021 17:20 JST
Jacobson Pharma's Proposed Spin-off and Separate Listing of JBM (Healthcare) Limited on The Main Board of The Stock Exchange of Hong Kong Limited
January 15 2021 23:25 JST
Jacobson Pharma Announces FY2021 Interim Results
November 27 2020 20:10 JST
More Press release >>